Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Obama Urges Lawmakers To Move Quickly On Health Bills
"After a weeklong overseas trip that pushed him to the fringes of Washington"s health care debate, Mr. Obama moved aggressively to reclaim control," the New York Times reports. "He summoned top Democrats to the White House to urge them to stick to his legislative timetable - he wants the House and the Senate to pass bills before the August recess - and appeared in the Rose Garden to cast himself as a kind of sheriff who had just come back to town."
generic viagra online
South Pole Doctor And Cancer Survivor Who Treated Herself 10 Years Ago Dies
A US doctor who diagnosed and treated herself for breast cancer while stationed in the South Pole during the winter of 1999, was then rescued
News of the day
Phase III Data Showed Novartis Investigational Bronchodilator QAB149 Significantly Improved Lung Function In COPD Patients
The Novartis investigational bronchodilator QAB149 (indacaterol) met the primary efficacy endpoints of improved lung function compared to placebo at 12 weeks in three pivotal phase III studies in chronic obstructive pulmonary disease (COPD) patients. In secondary endpoints of these studies, QAB149 demonstrated clinically relevant lung function improvements within five minutes of the first dose, lasting for 24 hours in COPD patients.
Medical Devices

Cost-Effectiveness Of HPV Vaccination In The Netherlands

Even under favorable assumptions, including lifelong protection against 70% of all cervical cancers and no side effects, vaccination against the human papillomavirus (HPV) is not cost-effective in the Netherlands, according to a study published online July 1 in the Journal of the National Cancer Institute. Researchers conducted the study because the cost effectiveness of HPV vaccination may be limited by the low number of cervical cancer cases and deaths in the region associated with the current Dutch cervical cancer screening program. In the study, Inge M.C.M. de Kok of the Department of Public Health at Erasmus MC, University Medical Center in Rotterdam, the Netherlands, and colleagues estimated the costs and effects of adding HPV vaccination to the current program (screening only) using a microsimulation screening analysis model. They found that adding HPV vaccination was not cost-effective, even under favorable assumptions. "To become cost-effective, the vaccine price would have to be decreased considerably, depending on the effectiveness of the vaccine," the authors write. Steve Graff Journal of the National Cancer Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009